NewsroomHome About Newsroom Page Navigation Press Releases Media CoveragePress Releases Press ReleaseDavide Molho, DVM, Life Sciences Industry Veteran joins BioAgilytix as CEOBioAgilytix Labs, LLC (BioAgilytix), a leading global bioanalytical laboratory, today announced the appointment of Davide Molho, DVM, as its new Chief Executive Officer (CEO) with… See all Press Releases Press ReleaseA3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USAA3P Biomedical AB, a Swedish company specialized in advanced prostate cancer diagnostics, and BioAgilytix, a global bioanalytical services provider, have entered a partnership with the… Press ReleaseBioAgilytix Commits to United Nations Global CompactLeading bioanalytical services provider pledges to act in support of human rights and environmental sustainability. DURHAM, NC, August 1, 2023 – BioAgilytix Labs, LLC (BioAgilytix),… Press ReleaseBioAgilytix Expands Hamburg Lab to Support Customer Drug Development from Early Phase to Market AuthorizationPCR platforms and Good Manufacturing Practices (GMP) certification further enhance European service offerings HAMBURG, GERMANY and DURHAM, NC, May 8, 2023/EINPresswire.com/ BioAgilytix Labs, LLC (BioAgilytix),… Media Coverage Media CoverageBoosting Hamburg as a Science and Pharmaceutical Location Together With BioAgilytixAndreas Rieckhof, State Councilor for Economic Affairs, LSN Managing Director Dr. Jürgen Walkenhorst and Juliane Worm, LSN Director Innovation & Technologies, visited the European headquarters… Media CoveragePre-existing Immunogenicity: How Will Cell and Gene Therapies Change Our Testing Approach?In this article, Chief Scientific Officer at BioAgilytix, Jim McNally, Ph.D., explores why bioanalysts should prepare for the impending wave of C>s entering the development… Media CoverageBioanalytical Needs And Biosimilars: How Does The Molecule Compare?Once the patent on a previously ground-breaking blockbuster molecule comes to an end, there is an opportunity for biosimilar versions of this product to enter… See all media coverage
